STOCK OPTIONS AND WARRANTS (Details 2) |
6 Months Ended |
---|---|
Jun. 30, 2020
shares
| |
Options Exercisable [Member] | |
Exercisable, Number of Options | 822,658 |
Options Exercisable [Member] | 5.01 And Up [Member] | |
Exercisable, Number of Options | 454,530 |
Options Exercisable [Member] | 2.51-5.00 [Member] | |
Exercisable, Number of Options | 37,778 |
Options Exercisable [Member] | 0.01-2.50 [Member] | |
Exercisable, Number of Options | 330,350 |
Options Outstanding [Member] | |
Weighted average remaining life in years | 6 years |
Number of options | 831,131 |
Options Outstanding [Member] | 5.01 And Up [Member] | |
Weighted average remaining life in years | 6 years 7 months 6 days |
Number of options | 457,447 |
Options Outstanding [Member] | 2.51-5.00 [Member] | |
Weighted average remaining life in years | 7 months 6 days |
Number of options | 43,334 |
Options Outstanding [Member] | 0.01-2.50 [Member] | |
Weighted average remaining life in years | 6 years |
Number of options | 330,350 |
X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|